Factors impacting the efficacy of the in-situ vaccine with CpG and OX40 agonist.
Pieper AA, Spiegelman DV, Felder MAR, Feils AS, Tsarovsky NW, Zaborek J, Morris ZS, Erbe AK, Rakhmilevich AL, Sondel PM.
Pieper AA, et al. Among authors: rakhmilevich al.
Cancer Immunol Immunother. 2023 Jul;72(7):2459-2471. doi: 10.1007/s00262-023-03433-3. Epub 2023 Apr 5.
Cancer Immunol Immunother. 2023.
PMID: 37016127
Free PMC article.